Jeremy B. Hayden, General Counsel & VP of BD at CYTORI THERAPEUTICS, INC. (CYTX), bought 8,200 shares at $0.36 ($3K) on 2015-09-02, disclosed to the SEC on 2015-09-03.
Open-market purchase of $3k CYTX by General Counsel & VP of BD. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| SGHT | SELL | 2026-01-21 | $42K | — | Filing → |
| SGHT | SELL | 2026-01-06 | $87K | — | Filing → |
| SGHT | SELL | 2025-11-26 | $362K | — | Filing → |